• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Daiwa ETF TOPIX-17 Pharmaceutical

+ Add to Watchlist

1638:JP

18,050.0000 JPY 500.0000 2.85%

As of 00:19:57 ET on 01/27/2015.

Snapshot for Daiwa ETF TOPIX-17 Pharmaceutical (1638)

Open: 17,920.0000 High - Low: 18,050.0000 - 17,920.0000 Primary Exchange: Tokyo
Volume: 40 52-Week Range: 13,440.0000 - 18,050.0000 Beta vs TP17PHRM: 0.8817

ETF Chart for 1638

No chart data available.
  • 1638:JP 18,050.0000
  • 1D
  • 1M
  • 1Y
17,550.0000
Interactive 1638 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1638

Daiwa ETF TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated i n Japan. The objective of the Fund is to provide investment results that c orrespond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-07-23 Telephone: -
Managers: -
Web Site: www.daiwa-am.co.jp

Fundamentals for 1638

NAV (on 2015-01-26) 17,741.0000
Assets (M) (on 2015-01-26) 501.0000
Shares out (M) 0.03
Market Cap (M) 509.73
% Premium -1.08
Average 52-Week % Premium -0.1455
Fund Leveraged N

Dividends for 1638

Dividend Type Distribution
Dividend Frequency Semi-Anl
Last Dividend Net (on 2015-01-16) 173.0000
Dividend Yield (ttm) 1.96%

Performance for 1638

1-Month +4.21% 1-Year +24.57%
3-Month +11.42% 3-Year +26.57%
Year To Date +4.03% 5-Year +13.24%
Expense Ratio 0.18

Top Fund Holdings for 1638

Filing Date: 12/30/2014
Name Position Value % of Total
Astellas Pharma Inc 61,000 102,876,500 21.567%
Takeda Pharmaceutical Co Ltd 20,100 100,429,650 21.054%
Otsuka Holdings Co Ltd 10,600 38,340,200 8.038%
Eisai Co Ltd 7,100 33,171,200 6.954%
Daiichi Sankyo Co Ltd 18,000 30,384,000 6.370%
Shionogi & Co Ltd 8,400 26,250,000 5.503%
Ono Pharmaceutical Co Ltd 2,400 25,752,000 5.399%
Chugai Pharmaceutical Co Ltd 5,300 15,709,200 3.293%
Santen Pharmaceutical Co Ltd 2,000 12,940,000 2.713%
Mitsubishi Tanabe Pharma Corp 6,200 10,974,000 2.301%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil